Humana AB (publ) (HUM.ST)

SEK 36.6

(3.39%)

EBITDA Summary of Humana AB (publ)

Humana AB (publ)'s latest annual EBITDA in 2023 was 457 Million SEK , down -49.22% from previous year.
Humana AB (publ)'s latest quarterly EBITDA in 2024 Q2 was 272 Million SEK , down -1.3% from previous quarter.
Humana AB (publ) reported an annual EBITDA of 901 Million SEK in 2022, down -2.81% from previous year.
Humana AB (publ) reported an annual EBITDA of 892 Million SEK in 2021, up 13.06% from previous year.
Humana AB (publ) reported a quarterly EBITDA of 350 Million SEK for 2024 Q3, up 53.51% from previous quarter.
Humana AB (publ) reported a quarterly EBITDA of 250 Million SEK for 2024 Q1, down -4.15% from previous quarter.

Annual EBITDA Chart of Humana AB (publ) (2023 - 2012)

Historical Annual EBITDA of Humana AB (publ) (2023 - 2012)

Year	EBITDA	EBITDA Growth
2023	457 Million SEK	-49.22%
2022	901 Million SEK	-2.81%
2021	892 Million SEK	13.06%
2020	842 Million SEK	12.35%
2019	710 Million SEK	60.93%
2018	440 Million SEK	22.1%
2017	371 Million SEK	-6.08%
2016	405 Million SEK	9.72%
2015	360 Million SEK	-0.55%
2014	301 Million SEK	40.86%
2013	257 Million SEK	21.43%
2012	211.64 Million SEK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	272 Million SEK	-1.3%
2024 Q3	350 Million SEK	53.51%
2024 Q1	250 Million SEK	-4.15%
2023 Q2	223 Million SEK	-11.51%
2023 Q1	252 Million SEK	6.33%
2023 Q4	240 Million SEK	-18.09%
2023 FY	- SEK	0.89%
2023 Q3	293 Million SEK	31.39%
2022 Q3	295 Million SEK	64.8%
2022 FY	- SEK	-2.81%
2022 Q1	190 Million SEK	-6.86%
2022 Q2	179 Million SEK	-5.79%
2022 Q4	237 Million SEK	-19.66%
2021 Q2	208 Million SEK	1.46%
2021 Q3	294 Million SEK	41.35%
2021 Q4	204 Million SEK	-30.61%
2021 FY	- SEK	13.06%
2021 Q1	205 Million SEK	6.22%
2020 Q1	190 Million SEK	131.71%
2020 Q3	266 Million SEK	37.11%
2020 Q4	193 Million SEK	-27.44%
2020 Q2	194 Million SEK	2.11%
2020 FY	- SEK	12.35%
2019 Q3	350 Million SEK	138.1%
2019 Q2	147 Million SEK	-2.65%
2019 FY	- SEK	60.93%
2019 Q1	151 Million SEK	60.64%
2019 Q4	82 Million SEK	-76.57%
2018 Q1	97 Million SEK	18.29%
2018 FY	- SEK	22.1%
2018 Q4	94 Million SEK	-44.38%
2018 Q3	169 Million SEK	81.72%
2018 Q2	93 Million SEK	-4.12%
2017 Q1	82 Million SEK	-7.87%
2017 FY	- SEK	-6.08%
2017 Q4	82 Million SEK	-35.94%
2017 Q3	128 Million SEK	43.82%
2017 Q2	89 Million SEK	8.54%
2016 Q4	89 Million SEK	-49.43%
2016 FY	- SEK	9.72%
2016 Q2	70 Million SEK	29.63%
2016 Q1	54 Million SEK	-40.0%
2016 Q3	176 Million SEK	151.43%
2015 Q3	138 Million SEK	283.33%
2015 Q1	95 Million SEK	0.0%
2015 Q2	36 Million SEK	-62.11%
2015 Q4	90 Million SEK	-34.78%
2015 FY	- SEK	-0.55%
2014 FY	- SEK	40.86%
2013 FY	- SEK	21.43%
2012 FY	- SEK	0.0%

Peer EBITDA Comparison of Humana AB (publ)

Name	EBITDA	EBITDA Difference
Ambea AB (publ)	2.28 Billion SEK	79.965%
Attendo AB (publ)	3.11 Billion SEK	85.329%
ProstaLund AB (publ)	-16.57 Million SEK	2857.664%